NSWIn ForceAct
Human Tissue Act 1983
27CAuthority to carry out ante-mortem procedures
Start here
Get a plain-English read of 27C
Turn the raw legal text into a practical explanation grounded in Human Tissue Act 1983.
#### 27C Authority to carry out ante-mortem procedures
27C Authority to carry out ante-mortem procedures
> > (1) A designated officer in relation to a hospital may authorise the carrying out of an ante-mortem procedure if the potential tissue donor provides consent.
>
> > (2) If the potential tissue donor lacks the capacity to provide consent under subsection (1), the designated officer may authorise the carrying out of an ante-mortem procedure if—
> >
> > > (a) there are one or more senior available next of kin of the potential tissue donor and a senior available next of kin provides consent under section 27D, or
> >
> > > (b) there are no known senior available next of kin of the potential tissue donor and the designated officer is satisfied that—
> > >
> > > > (i) the potential tissue donor has, during the potential tissue donor’s lifetime, provided consent in writing to the removal of tissue for a relevant purpose, and
> > >
> > > > (ii) the consent has not been revoked, and
> > >
> > > > (iii) the potential tissue donor has not expressed an objection to the carrying out of an ante-mortem procedure on the potential tissue donor.
>
> > (3) Despite subsections (1) and (2), a designated officer must not give an authorisation unless—
> >
> > > (a) the designated officer is reasonably satisfied an authorisation to remove tissue after the death of the potential tissue donor under the Act, Part 4 will be given, and
> >
> > > (b) a prescribed practitioner has certified in writing that the prescribed practitioner is reasonably satisfied—
> > >
> > > > (i) the death of the potential tissue donor is imminently expected, and
> > >
> > > > (ii) the carrying out of an ante-mortem procedure on the potential tissue donor will not—
> > > >
> > > > > (A) hasten the death of the potential tissue donor, or
> > > >
> > > > > (B) cause more than minimal harm to the potential tissue donor, or
> > > >
> > > > > (C) cause undue risk to the potential tissue donor.
>
> > (4) In this section—
> >
> > experienced medical practitioner means a medical practitioner who has been a registered medical practitioner for at least 5 years.
> >
> > prescribed practitioner means a designated specialist or, if a designated specialist is not available, an experienced medical practitioner, who is not involved in—
> >
> > > (a) transplantation procedures, or
> >
> > > (b) the care of the potential tissue donor, or
> >
> > > (c) the care of a potential recipient of tissue.
>
> **s 27C:** Ins 2024 No 13, Sch 1\[2\].